Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer

被引：163

作者：

Stolzenberg-Solomon, Rachael Z. ^{[1
]}

Jacobs, Eric J. ^{[2
]}

Arslan, Alan A. ^{[3
]}

Qi, Dai ^{[4
]}

Patel, Alpa V. ^{[2
]}

Helzlsouer, Kathy J. ^{[5
,6
]}

Weinstein, Stephanie J. ^{[1
]}

McCullough, Marjorie L. ^{[2
]}

Purdue, Mark P. ^{[1
]}

Shu, Xiao-Ou ^{[4
]}

Snyder, Kirk ^{[7
]}

Virtamo, Jarmo ^{[8
]}

Wilkins, Lynn R. ^{[9
]}

Yu, Kai ^{[1
]}

Zeleniuch-Jacquotte, Anne ^{[3
]}

Zheng, Wei ^{[4
]}

Albanes, Demetrius ^{[1
]}

Cai, Qiuyin ^{[4
]}

Harvey, Chinonye ^{[10
]}

Hayes, Richard ^{[1
]}

Clipp, Sandra ^{[5
,6
]}

Horst, Ronald L. ^{[11
]}

Irish, Lonn ^{[7
]}

Koenig, Karen ^{[3
]}

Le Marchand, Loic ^{[9
]}

Kolonel, Laurence N. ^{[9
]}

机构：

[1] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20852 USA

[2] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA

[3] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA

[4] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Vanderbilt Ingram Canc Ctr,Div Epidemiol,Dept Med, Nashville, TN 37212 USA

[5] Mercy Med Ctr, Weinberg Ctr Womens Hlth & Med, Prevent & Res Ctr, Baltimore, MD USA

[6] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA

[7] Informat Management Serv Inc, Silver Spring, MD USA

[8] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland

[9] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA

[10] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA

[11] Heartland Assays Inc, Ames, IA USA

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2010年 / 172卷 / 01期

基金：

美国国家卫生研究院;

关键词：

case-control studies; cohort studies; pancreatic neoplasms; prospective studies; vitamin D; VITAMIN-D STATUS; D ANALOGS; MORTALITY; INSULIN; PROLIFERATION; EXPRESSION; DESIGN; COHORT; PREVENTION; RATIONALE;

D O I：

10.1093/aje/kwq120

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Results from epidemiologic studies examining pancreatic cancer risk and vitamin D intake or 25-hydroxyvitamin D (25(OH)D) concentrations (the best indicator of vitamin D derived from diet and sun) have been inconsistent. Therefore, the authors conducted a pooled nested case-control study of participants from 8 cohorts within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP) (1974-2006) to evaluate whether prediagnostic circulating 25(OH)D concentrations were associated with the development of pancreatic cancer. In total, 952 incident pancreatic adenocarcinoma cases occurred among participants (median follow-up, 6.5 years). Controls (n = 1,333) were matched to each case by cohort, age, sex, race/ethnicity, date of blood draw, and follow-up time. Conditional logistic regression analysis was used to calculate smoking-, body mass index-, and diabetes-adjusted odds ratios and 95% confidence intervals for pancreatic cancer. Clinically relevant 25(OH)D cutpoints were compared with a referent category of 50-< 75 nmol/L. No significant associations were observed for participants with lower 25(OH)D status. However, a high 25(OH)D concentration (>= 100 nmol/L) was associated with a statistically significant 2-fold increase in pancreatic cancer risk overall (odds ratio = 2.12, 95% confidence interval: 1.23, 3.64). Given this result, recommendations to increase vitamin D concentrations in healthy persons for the prevention of cancer should be carefully considered.

引用

页码：81 / 93

页数：13

共 49 条

[31] Latitude Variation in Pancreatic Cancer Mortality in Australia [J].

Neale, Rachel E. ;

Youlden, Danny R. ;

Krnjacki, Lauren ;

Kimlin, Michael G. ;

van der Pols, Jolieke C. .

PANCREAS, 2009, 38 (04) :387-390

[32]

Pettersson F, 2000, BRIT J CANCER, V83, P239

[33] Interactions between Sec complex and prepro-α-factor during posttranslational protein transport into the endoplasmic reticulum [J].

Plath, K ;

Wilkinson, BM ;

Stirling, CJ ;

Rapoport, TA .

MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (01) :1-10

[34] 19-nor-1α,25-dihydroxyvitamin D2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo [J].

Schwartz, Gary G. ;

Eads, Dawn ;

Naczki, Christine ;

Northrup, Scott ;

Chen, Tai ;

Koumenis, Constantinos .

CANCER BIOLOGY & THERAPY, 2008, 7 (03) :430-436

[35] Pancreatic cancer cells express 25-hydroxyvitamin D-1α-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3 [J].

Schwartz, GG ;

Eads, D ;

Rao, A ;

Cramer, SD ;

Willingham, MC ;

Chen, TC ;

Jamieson, DP ;

Wang, LL ;

Burnstein, KL ;

Holick, MF ;

Koumenis, C .

CARCINOGENESIS, 2004, 25 (06) :1015-1026

[36] Vitamin D intake and the risk for pancreatic cancer in two cohort studies [J].

Skinner, Halcyon G. ;

Michaud, Dominique S. ;

Giovannucci, Edward ;

Willett, Walter C. ;

Colditz, Graham A. ;

Fuchs, Charles S. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (09) :1688-1695

[37] A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers [J].

Stolzenberg-Solomon, Rachael Z. ;

Vieth, Reinhold ;

Azad, Azar ;

Pietinen, Pirjo ;

Taylor, Philip R. ;

Virtamo, Jarmo ;

Albanes, Demetrius .

CANCER RESEARCH, 2006, 66 (20) :10213-10219

[38] Serum Vitamin D and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Screening Trial [J].

Stolzenberg-Solomon, Rachael Z. ;

Hayes, Richard B. ;

Horst, Ron L. ;

Anderson, Kristin E. ;

Hollis, Bruce W. ;

Silverman, Debra T. .

CANCER RESEARCH, 2009, 69 (04) :1439-1447

[39] Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers [J].

Stolzenberg-Solomon, RZ ;

Graubard, BI ;

Chari, S ;

Limburg, P ;

Taylor, PR ;

Virtamo, J ;

Albanes, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (22) :2872-2878

[40] A PROSPECTIVE-STUDY OF ENDOGENOUS ESTROGENS AND BREAST-CANCER IN POSTMENOPAUSAL WOMEN [J].

TONIOLO, PG ;

LEVITZ, M ;

ZELENIUCHJACQUOTTE, A ;

BANERJEE, S ;

KOENIG, KL ;

SHORE, RE ;

STRAX, P ;

PASTERNACK, BS .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :190-197

← 1 2 3 4 5 →